Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1,3,5-Trimethoxybenzene
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
1,3,5-Trimethoxybenzene is a small molecule antispasmodic drug used primarily for the symptomatic treatment of spastic pain in the urinary tract (such as renal colic), painful disorders of the digestive and biliary tract, and gynecological pain. It acts on smooth muscle to relieve spasms. The compound is also known as a major scent component in Chinese rose and serves as an intermediate in organic synthesis. In France and some other countries it is marketed under the brand name Spasfon for these indications[4][6].
- Brand names
- Spasfon
- Other names
- 1,3,5-Trimethyoxybenzenephloroglucinol trimethyl ethersym-trimethoxybenzene
Beyond the preview
Go deeper on 1,3,5-Trimethoxybenzene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1,3,5-Trimethoxybenzene.